Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
Core clinical pharmacology principles must be considered when designing and executing neonatal clinical trials. In this review, the authors discuss important aspects of drug dose selection, pharmacokinetics, pharmacogenetics and pharmacodynamics that stakeholders may consider when undertaking a neon...
Main Authors: | Cindy Hoi Ting Yeung, Ruud H. J. Verstegen, Rachel Greenberg, Tamorah Rae Lewis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1345969/full |
Similar Items
-
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01) -
Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates
by: Mario Regazzi, et al.
Published: (2023-12-01) -
Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
by: Yangyang Gao, et al.
Published: (2025-01-01) -
Pharmacokinetic and pharmacodynamic evaluation of various vasopressin doses and routes of administration in a neonatal piglet model
by: Marwa Ramsie, et al.
Published: (2024-10-01) -
Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
by: Yue-E Wu, et al.
Published: (2022-12-01)